NorthEdge Completes Multi‑Million‑Pound Investment into Antibody Analytics
November 2, 2023
NorthEdge has completed a multi‑million‑pound growth investment in Antibody Analytics (now trading as RoukenBio), a Scotland‑based pre‑clinical immunology CRO. The capital will fund site expansion, upgraded facilities and job creation as NorthEdge (represented on the board by Liam May) backs CEO Andy Upsall and the leadership team to scale the business internationally.
- Buyers
- NorthEdge
- Targets
- Antibody Analytics (RoukenBio)
- Industry
- Biotechnology
- Location
- Scotland, United Kingdom
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.